PR Newswire Consumer Products
pressCenter
International B-SILENT Study of Venous Stenting for Pulsatile Tinnitus Enrolls First Patient in Toronto Hospitaltranslating…
LAKE FOREST, Calif., Sept. 1, 2026 /PRNewswire/ -- Sonorous Neurovascular, a medical device company focused on cerebral venous diseases and neurovascular interventions, today announced that it has enrolled its first patient at a Toronto hospital in B-SILENT (NCT07070089), an…
Keywords#Toronto Hospital#B-SILENT#Patient#Venous#B-SILENT Study